Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome

Tropical Medicine and International Health

Volumn 4, Issue 12, 1999, Pages 801-811

  Salaiza Suazo, Norma ^b   Volkow, Patricia ^b   Pérez Tamayo, Ruy ^b   Moll, Heidrun ^b   Gillitzer, Reinhard ^b   Pérez Torres, Armando ^b   Pérez Montfort, Ruy ^b   Delgado Domínguez, Jose ^b   Velasco Castrejón, Oscar ^b   Crippa, Marco ^b   Becker, Ingeborg ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b NONE

Author keywords

Diffuse cutaneous leishmaniasis; Immunocytochemistry; Langerhans cells; Leishmania mexicana; Monocytes; NK and CD8+ lymphocytes; Respiratory burst

Indexed keywords

ALLOPURINOL; ANTILEISHMANIAL AGENT; PENTAMIDINE; RECOMBINANT GAMMA INTERFERON;

DISEASE CONTROL; HEALTH CARE; LEISHMANIASIS;

ARTICLE; CASE REPORT; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOMODULATION; LANGERHANS CELL; LEISHMANIA MEXICANA; RESPIRATORY BURST; SKIN LEISHMANIASIS; T LYMPHOCYTE SUBPOPULATION;

LEISHMANIA MEXICANA; PROTOZOA;

EID: 0033452407     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1999.00491.x     Document Type: Article

References (35)

1. Badaro R, Falcoff E, Badaro FS et al. (1990) Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. The New England Journal of Medicine 322, 16-21.
2. Badaro R & Johnson WD (1993) The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis. Journal of Infectious Diseases 167, 13-17.
3. Barral-Netto M, Barral A, Brodskyn C, Carvalho EM & Reed SG (1995) Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunology 17, 21-28.
4. Becker I, Volkow P, Velasco-Castrejón O et al. (1999) The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis. Parasitology Research 85, 165-170.
5. Bogdan C, Gessner A, Solbach W & Röllinghoff M (1996) Invasion, control and persistence of Leishmania parasites. Current Opinion in Immunology 8, 517-525.
6. Bogdan C & Röllinghoff M (1996) The impact of the type 1 and type 2 T helper concept on novel vaccine design with emphasis on protection against Leishmania parasites. In Concepts in Vaccine Development (ed. SHE Kaufmann), Walter de Gruyter, Berlin, pp. 143-180.
7. Bomfim G, Nascimento C, Costa J, Carvalho EM, Barral-Netto M & Barral A (1996) Variation of cytokine patterns related to therapeutic responses in diffuse cutaneous leishmaniasis. Experimental Parasitology 84, 188-194.
8. Brodskyn CI, Barral A, Boaventura V, Carvalho E & Barral-Netto M (1997) Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. Journal of Immunology 159, 4467-4473.
9. Bryceson ADM (1970) Diffuse cutaneous leishmaniasis in Ethiopia. II Treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 369-379.
10. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC & Kaye PM (1998) Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. European Journal of Immunology 28, 669-680.
11. Gillitzer R, Berger R & Moll H (1990) A reliable method for simultaneous demonstration of two antigens using a novel combination of immunogold-silver staining and immunoenzymatic labeling. Journal of Histochemistry and Cytochemistry 38, 307-313.
12. Gorak PM, Engwerda CR & Kaye PM (1998) Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. European Journal of Immunology 28, 687-695.
13. Ghosh MK, Ghosh AK, Addy M, Nandy A & Ghose AC (1996) Subpopulation of T lymphocytes in the peripheral blood and lymph nodes of Indian kala-azar patients. Medical Microbiology and Immunology 185, 183-187.
14. Kemp M (1997) Regulator and effector functions of T-cell subsets in human Leishmania infections. Acta Pathologica Microbiologica et Immunologica Scandinavica 68, 1-33.
15. Kima PE, Ruddle NH & McMahon-Pratt D (1997) Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endosomal antigen to CD8+ T cells. Journal of Immunology 159, 1828-1834.
16. Konecny P, Stagg AJ, Jebbari H, English N, Davidson RN & Knight SC (1999) Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. European Journal of Immunology 29, 1803-1811.
17. Laochumroonvorapong P, Wang J, Liu CC et al. (1997) Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infection and Immunity 65, 127-132.
18. Laskay T, Diefenbach A, Röllinghoff M & Solbach W (1995) Early parasite containment is decisive for resistance to Leishmania major infection. European Journal of Immunology 25, 2220-2227.
19. Lewis DJ (1987) Depth of penetration of vertebrate skin by phlebotomine sandflies (Diptera psychodae). Annals of Tropical Medicine and Parasitology 81, 173-179.
20. Liew FY, Li Y, Moss D, Parkinson C, Rogers MV & Moncada S (1991) Resistance to Leishmania major infection correlates with the initiation of nitric oxide synthase in murine macrophages. European Journal of Immunology 21, 3009-3014.
21. Locksley RM & Klebanoff SJ (1983) Oxygen-dependent microbicidal systems of phagocytes and host defense against intracellular protozoa. Journal of Cellular Biochemistry 22, 173-185.
22. Locksley RM, Heinzel FP, Fankhauser JE, Nelson CS & Sadick MD (1988) Cutaneous host defense in leishmaniasis: Interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote. Infection and Immunity 56, 336-342.
23. López JA, LeBowitz JH, Beverly SM, Rammensee HG & Overath P (1993) Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages. European Journal of Immunology 23, 217-223.
24. Maasho K, Sanchez F, Schurr E, Hailu A & Akuffo H (1998) Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infection and Immunity 66, 2698-2704.
25. Moll H (1993) Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunology Today 14, 383-387.
26. Moll H, Flohe S & Röllinghoff M (1995) Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. European Journal of Immunology 25, 693-699.
27. Murray HW, Rubin BY & Rothermel CD (1983) Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes: Evidence that interferon gamma is the activating lymphokine. Journal of Clinical Investigation 72, 1506-1510.
28. Reiner SL & Locksley R (1995) The regulation of immunity to Leishmania major. Annual Review of Immunology 13, 151-177.
29. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O & Carvalho EM (1998) Cytokine profile and pathology in human leishmaniasis. Brazilian Journal of Medical and Biological Research 31, 143-148.
30. Scharton TM & Scott P (1993) Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. Journal of Experimental Medicine 178, 567-577.
31. Scharton-Kersten T & Scott P (1995) The role of the innate immune response in Th1 cell development following Leishmania major infection. Journal of Leukocyte Biology 57, 515-522.
32. Smith LE, Rodrigues M & Russel DG (1991) The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages. Journal of Experimental Medicine 174, 499-505.
33. Tapia FJ, Caceres-Dittmar G, Sanchez MA, Fernandez AE & Convit J (1993) The cutaneous lesion in American leishmaniasis: Leukocyte subsets, cellular interaction and cytokine production. Biological Research 26, 239-247.
34. Teklemariam S, Hiwot AG, Frommel D, Miko TL, Ganlov G & Bryceson A (1994) Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 334-339.
35. Velasco-Castrejon O (1994) Las Leishmaniasis con Especial Referencia a México. Publicación Técnica no, 7. Instituto Nacional de Diagnóstico Y Referencia Epidemiológica, Secretaria de Salubridad Y Asistencia, México. 7, 9-25.